glp-1 clinical trial GLP1 agonists: current and future landscape of trials for patients with metabolic dysfunction How Can GLP-1 Agonists Be
Description
Although cotadutide has progressed well through clinical trials, other GLP-1/glucagon co-agonists have shown mixed results
J Cell Sci 2021;134:jcs257337
NNMT is a cytosolic enzyme that methylates nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as a methyl donor
One downside of the current generation of GLP-1 drugs is that they have to be administered using an injector
No FDA warning letter on Olympia
The $99 test maps 14 metabolic pathways across 49 peptides, identifying genetic variants in GLP1R, GIPR, FTO, and MC4R that predict your individual response to GLP-1 therapy
